8-K: Ensign Group Reports Strong 2023 Results and Issues Optimistic 2024 Guidance

The Ensign Group announced a 23.3% increase in annual revenue and a 15.2% increase in adjusted earnings per share for 2023, alongside issuing a positive 2024 earnings guidance.

Summary

• The Ensign Group reported its financial results for the fourth quarter and full year of 2023, showing significant growth in revenue and earnings.
• Consolidated GAAP revenue for the year reached $3.73 billion, a 23.3% increase compared to the previous year.
• Adjusted earnings per share for the year were $4.77, a 15.2% increase year-over-year.
• For the fourth quarter, consolidated GAAP revenue was $980.4 million, a 21.1% increase over the same quarter last year.
• Adjusted earnings per share for the quarter were $1.28, a 16.4% increase year-over-year.
• The company's same-store occupancy increased by 3.2% over the prior year and 2.4% over the prior year quarter.
• The company also saw a 3.2% increase in transitioning occupancy over the prior year and 1.5% over the prior year quarter.
• Total skilled services revenue was $3.58 billion for the year, a 23.1% increase year-over-year.
• Standard Bearer revenue was $82.5 million for the year, a 13.1% increase year-over-year.
• The company issued 2024 earnings guidance of $5.29 to $5.47 per diluted share and revenue guidance of $4.13 billion to $4.17 billion.
• The midpoint of the 2024 earnings guidance represents a 13% increase over 2023 results and is 30% higher than 2022 results.
• The company has $509.6 million of cash on hand and $593.7 million of available capacity under its line-of-credit.
• The company acquired three new operations and one real estate asset during the quarter and since, bringing the total to 54 acquisitions since 2022.
• The company's portfolio consists of 299 healthcare operations, 27 of which include senior living operations, across 14 states.
• Ensign owns 113 real estate assets, 83 of which it operates.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to strong financial results, significant growth, and optimistic future guidance. The company's strategic acquisitions and strong liquidity position further contribute to the positive outlook.

Positives

• The company experienced significant revenue growth of 23.3% for the year and 21.1% for the quarter.
• Adjusted earnings per share increased by 15.2% for the year and 16.4% for the quarter.
• Same-store occupancy improved to 79.9%, showing strong operational performance.
• The company issued strong 2024 earnings and revenue guidance, indicating continued growth.
• The company has a strong liquidity position with significant cash on hand and available credit.
• The company continues to expand its portfolio through strategic acquisitions.
• The company increased its annual dividend for the 21st consecutive year in December 2023.

Negatives

• GAAP diluted earnings per share for the year was $3.65 and $0.38 for the quarter, which includes the impact of certain litigation matters arising outside the ordinary course of business.
• The skilled mix by nursing days decreased slightly in same store facilities by 1.8% for the quarter and 1.1% for the year.
• The skilled mix by nursing revenue decreased slightly in same store facilities by 2.7% for the quarter and 1.9% for the year.

Risks

• The company faces risks related to reduced prices and reimbursement rates for its services.
• The company's ability to manage increasing borrowing costs is a risk as it incurs additional debt for acquisitions.
• The company's operating margins and profitability could suffer if it is unable to manage its increasing number of operations effectively.
• The company faces competition from other companies in the acquisition, development, and operation of facilities.
• The company is subject to litigation and regulatory-related claims.
• Changes in government regulations could limit the company's business operations or require significant expenditures.
• The company's business and operations continue to be impacted by the unprecedented nature of the changes in the regulations and environment.

Future Outlook

The company issued 2024 earnings guidance of $5.29 to $5.47 per diluted share and annual revenue guidance of $4.13 billion to $4.17 billion, with the midpoint of the earnings guidance representing a 13% increase over 2023 results and 30% higher than 2022 results.

Management Comments

• Our local teams have once again posted impressive clinical and financial results and continue to build remarkable momentum in each market across our portfolio, said Barry Port, Ensign's Chief Executive Officer.
• We are very humbled by what we were able to accomplish in 2023, but we are eager to continue to drive improvements in our existing portfolio and to take advantage of the acquisition opportunities that we see on the horizon, said Barry Port, Ensign's Chief Executive Officer.
• As we expected, we continued to add to our growing portfolio and are very excited about the three new operations and one real estate asset we added during the quarter and since, bringing the number of operations acquired since 2022 to 54, said Chad Keetch, Ensign's Chief Investment Officer and Executive Vice President.
• The pipeline for new deals remains strong. We are lining up several exciting opportunities and expect to announce several deals over the coming months, said Chad Keetch, Ensign's Chief Investment Officer and Executive Vice President.
• We remain poised to grow with over a billion dollars in dry powder for future investments and our local leaders continue to recruit future CEOs of Ensign affiliated operations, said Chad Keetch, Ensign's Chief Investment Officer and Executive Vice President.
• The company plans to continue its long history of paying dividends into the future, noting that in December of 2023 the Company increased the annual dividend for the 21st consecutive year, said Suzanne Snapper, Ensign's Executive Vice President and Chief Financial Officer.

Industry Context

The Ensign Group's strong performance and expansion align with the growing demand for post-acute healthcare services, particularly in skilled nursing and senior living facilities. The company's focus on acquisitions and operational improvements positions it well within the competitive landscape of the healthcare industry.

Comparison to Industry Standards

• While specific competitor data is not provided in the document, Ensign's 23.3% revenue growth and 15.2% adjusted EPS growth for the year are strong indicators of performance in the healthcare sector.
• The company's same-store occupancy increase of 3.2% year-over-year suggests effective management and patient retention, which is a key metric in the skilled nursing industry.
• The company's acquisition strategy, with 54 operations acquired since 2022, demonstrates a commitment to growth, which is a common strategy among healthcare providers.
• The company's focus on both leasing and acquiring real estate is a common strategy in the healthcare industry, allowing for flexibility and growth.
• The company's strong liquidity position with $509.6 million in cash and $593.7 million available under its line of credit is a positive sign compared to industry standards, indicating financial stability and the ability to pursue further growth opportunities.

Legal Proceedings

• The company's GAAP earnings include the impact of certain litigation matters arising outside the ordinary course of business.

Related Party Transactions

• Standard Bearer has intercompany agreements with the Company and its independent subsidiaries, including the Service Center, for management fees and interest.

Stakeholder Impact

• Shareholders are positively impacted by the strong financial results, increased dividends, and positive future guidance.
• Employees are likely to benefit from the company's growth and expansion.
• Customers (patients and residents) are expected to benefit from the company's focus on operational improvements and quality of care.
• Suppliers and creditors are likely to view the company's strong financial position favorably.

Next Steps

• The company plans to continue its acquisition strategy, with several deals expected to be announced in the coming months.
• The company will continue to focus on operational improvements in both existing and newly acquired facilities.
• The company will continue to pay dividends to shareholders.

Key Dates

Keywords

healthcare, skilled nursing, senior living, acquisitions, revenue, earnings, occupancy, EBITDA, financial results, real estate